While preclinical data suggest that cancer treatment may be enhanced via inhibiting these proteins with antagonist molecules, downregulation by means of intense lifestyle changes, dietary alterations, or modulation of insulin/glucose through diabetic medication remains less clear in practice (5, 6). Here, INS is linked to cancer.